Nate Hukill - Profile and Investment Details

Investor Profile

Nate Hukill is a Venture Capital, Private Equity Firm based in Puerto Rico with a diverse investment portfolio that includes companies such as HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems, TriVascular, Ceterix Orthopaedics, Omeros, Benvenue Medical, AFT Pharmaceuticals, Outset Medical, Good Start Genetics, BioDelivery Sciences International, Valeritas, Intrinsic Therapeutics, NanoString Technologies, Endoceutics, Harmony Biosciences, GenomeDx Biosciences, Bioniche Pharma Group, Blue Belt Technologies, TearLab Corporation, Exagen, Nevro, Avinger, Strongbridge Biopharma, SOC Telemed, Solta Medical, Corium International, Iroko Pharmaceuticals, Cardiome Pharma, ViewRay, Synergy Pharmaceuticals, Autonomic Technologies, EndoGastric Solutions, US WorldMeds, Biodesix, Silk Road MedicalTandem Diabetes Care, RainDance Technologies, Earlens Corporation, Hicuity Health, Inc., . Over time, Nate Hukill has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nate Hukill is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Investment Management, Biotechnology, Health Diagnostics, Medical, Big Data, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Nate Hukill, as their portfolio suggests a familiarity and interest in this area.

Understanding Nate Hukill’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.